Preeclampsia: Are platelet count and indices useful for its prognostic?

Hematology

Volumn 18, Issue 6, 2013, Pages 360-364

  Freitas, Letícia Gonçalves ^a   Alpoim, Patrícia Nessralla ^a   Komatsuzaki, Flávia ^a   Carvalho, Maria das Graças ^a   Dusse, Luci Maria S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Platelet indices; Preeclampsia; Prognostic value

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; PLATELETCRIT; PLETELET DISTRIBUTION WIDTH; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; PLATELET COUNT; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; YOUNG ADULT;

EID: 84885718610     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845413Y.0000000098     Document Type: Article

References (40)

1. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:1-22
2. Sibai BM, Caritis SN, Thom E, Klebanoff M, Mcnellis D, Rocco L, et al. National Institute of Child Health And Human Development Network of Maternal-Fetal Medicine Units Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med. 1993;329:1213-8.
3. Gilabert J, Estellés A, España F, Grancha S, Aznar J. Modificaciones de la hemostasia en obstetricia. Rev Iber Tromb Hemost. 1995;8:102-12.
4. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Espana F, et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe pre-eclampsia. Thromb Haemost. 1998;79:500-8.
5. Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol. 2011; 30:1-14.
6. Inglis TCM, Stuart J, George AJ, Davies AJ. Hemostatic and rheological changes in normal pregnancy and pre-eclampsia. Br J Haematol. 1982;50:461-5.
7. Konijnenberg A, Stokkers EW, Post JAMVD, Schaap MCL, Boer K, Bleker OP, et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol. 1997;176:461-9.
8. Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnancy women prior the development of preeclampsia. Thromb Haemost. 1995;74: 1052-63.
9. Fitzgerald DJ, Stephen SE, Mulloy K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75(5):956-63.
10. Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, et al. Endothelial-derived relaxing factor relesead by endothelial cells of umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991;164: 507-13.
11. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 1994;171:944-8.
12. Lind SE, Marks PW, Ewenstein BM. Haemostasis. In: Handin RI, Lux SE, Stossel TP (eds.). Blood: principles, practice of hematology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 959-1080.
13. Uysal P, Tuncel T, Olmez D, Babayigit A, Karaman O, Uzuner N. The role of mean platelet volume predicting acute exacerbations of cystic fibrosis in children. Ann Thorac Med. 2011; 6(4):227-30.
14. Bessman JD, Williams LJ, Gilmer PR. The inverse relation of platelet size and count in normal subjects, and an artifact of other particles. Am J Clin Pathol. 1981;76(3):289-93.
15. Giles C. The platelet count and mean platelet volume. Br J Haematol. 1981;48:31-7.
16. Walker JJ, Cameron AD, Bjornsson S, Singer CR, Fraser C. Can platelet volume predict progressive hypertensive disease in pregnancy? Am J Obstet Gynecol. 1989;161(3):676-9.
17. Bessman JD, Williams LJ, Gilmer PR. Platelet size in health and hematologic disease. Am J Clin Pathol. 1982;78(2):150-3.
18. Ahmed Y, van Iddekinge B, Paul C, Sullivan HF, Elder MG. Retrospective analyses of platelet numbers and volumes in normal pregnancy and in preeclampsia. Br J Obstet Gynaecol. 1993;100(3):216-20.
19. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7(2):157-61.
20. Howarth S, Marshall LR, Barr AL, Evans S, Pontre M, Ryan N. Platelet indices during normal pregnancy and pre-eclampsia. Br J Biomed Sci. 1999;56(1):20-2.
21. Järemo P, Lindahl TL, Lennmarken C, Forsgren H. The use of platelet density and volume measurements to estimate the severity of preeclampsia. Eur J Clin Invest. 2000;30(12):1113-8.
22. Chu AJ. Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam. 2011;2011:1-30.
23. Dundar O, Yoruk P, Tutuncu L, Erikci AA, Muhcu M, Ergur AR, et al. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of preeclampsia. Prenat Diagn. 2008;28(11):1052-6.
24. Subbs TM, Lazarchick J, van Dorsten JP, Cox J, Loadholt CB. Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol. 1986;155(2):263-5.
25. Tygart SG, Mcroyan DK, Spinnato JA, Mcroyan CJ, Kitay DZ. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol. 1986;154(4):883-7.
26. Martinez EZ, Louzada-Neto F, Pereira BB. A curva ROC para testes diagnósticos. Cadernos Saúde Coletiva. 2003;11(1):7-31.
27. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Ann Rev Pathol. 2010;5:173-92.
28. Trudinger BJ. Platelets and intrauterine growth retardation in preeclampsia. Br J Obstet Gynaecol. 1976;83(4):284-6.
29. Redman CWG, Bonnar J, Beilin L. Early platelet consumption in preeclampsia. Br Med J. 1978;1:467-9.
30. Giles C, Inglis TC. Thrombocytopenia and macrothrombocytosis in gestational hypertension. Br J Obstet Gynaecol. 1981; 88(11):1115-9.
31. Glanville T, Walker JJ. Pre-eclampsia: etiology and clinical practice. Cambridge University press, United Kingdom; 1989. p. 357-68
32. Redman CW. Platelets and the beginnings of preeclampsia. N Engl J Med. 1990;323(7):478-80.
33. Hutt R, Ogunniyi SO, Sullivan MH, Elder MG. Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol. 1994;83(1):146-9.
34. Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in preeclampsia and pregnancy. Clin Sci. 1994;86(6):731-9.
35. Makuyana D, Mahomed K, Shukusho FD, Majoko F. Liver and kidney function tests in normal and pre-eclamptic gestation-a comparison with non-gestational reference values. Cent Af J Med. 2002;48(5-6):55-9.
36. Ceyhan T, Beyan C, Başer İ, Kaptan K, Güngör S, Ifran A. The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume. Ann Hematol. 2006;85(5):320-2.
37. Piazze J, Gioia S, Maranghi L, Anceschi M. Mean platelet and red blood cell volume measurements to estimate the severity of hypertension in pregnancy. J Perinat Med. 2006;34(3):246-7.
38. Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides KH. Platelet changes and subsequent development of preeclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstet Gynecol. 2002;19(5):443-8.
39. Gioia S, Piazze J, Anceschi MM, Cerekja A, Alberini A, Giancotti A, et al. Mean platelet volume: association with adverse neonatal outcome. Platelets 2007;18(4):284-8.
40. Medronho RA, Boch KV, Luiz RR, Werneck GL. Epidemiologia. 2nd ed. São Paulo: Atheneu; 2009. 685p.